The investigational intranasal L-type calcium channel blocker etripamil continues to be well tolerated and effective for self-treating recurrent episodes of paroxysmal supraventricular tachycardia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback